Cytokine responses in a severe case of glandular fever treated successfully with foscarnet combined with prednisolone and intravenous immunoglobulin

Viral loads and cytokine responses Epstein–Barr virus (EBV) were measured in an 18‐year‐old boy with severe glandular fever complicated by a mild anaemia, severe thrombocytopaenia and neutropaenia. Hepatosplenomegaly was detected by abdominal ultrasound in the presence of significant hepatitis. Cytokine testing demonstrated elevated cell‐mediated Th1 (IFN‐γ, IL‐12, sTNFR1, CXCL10, CXCL9 and CCL3) and humoral Th2 (IL‐4) immune responses. Serum antibodies to EBV virus capsid antigen (VCA) IgM and IgG antibodies were detected, together with a raised EBV DNA level (up to about 70,000 DNA copies/mL) in the acute phase of the illness. This EBV DNA load decreased rapidly in response to treatment with a combination of foscarnet, intravenous immunoglobulin and prednisolone, and the boy's symptoms settled eventually after approximately 50 days of illness, following this combined antiviral and immune‐modulating therapy. Detailed immunological, virological, haematological and biochemical laboratory parameters are presented to document this patient's severe EBV disease and eventual recovery. J. Med. Virol. 81:99–105, 2009. © 2008 Wiley‐Liss, Inc.

[1]  J. Sung,et al.  Cytokine profile in fatal human immunodeficiency virus tuberculosis Epstein-Barr virus associated hemophagocytic syndrome. , 2007, Archives of internal medicine.

[2]  Tohru Takahashi,et al.  Methylprednisolone pulse therapy for severe immune thrombocytopenia associated with infectious mononucleosis , 2007, American journal of hematology.

[3]  H. Balfour,et al.  A virologic pilot study of valacyclovir in infectious mononucleosis. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[4]  A. Rickinson,et al.  Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. , 2007, Annual review of immunology.

[5]  G. Garas,et al.  Ganciclovir and the treatment of Epstein‐Barr virus hepatitis , 2006, Journal of gastroenterology and hepatology.

[6]  Richard C Brundage,et al.  A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis. , 2005, The Journal of infectious diseases.

[7]  L. Silverman,et al.  Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy. , 2004, Blood.

[8]  A. Swerdlow,et al.  Analysis of immune activation and clinical events in acute infectious mononucleosis. , 2004, The Journal of infectious diseases.

[9]  J. Sung,et al.  Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome , 2004, Clinical and experimental immunology.

[10]  P. Pellett,et al.  Comparison of human herpesvirus 8 and Epstein–Barr virus seropositivity among children in areas endemic and non‐endemic for Kaposi's sarcoma , 2004, Journal of medical virology.

[11]  M. Corsi,et al.  High Th1-type cytokine serum levels in patients with infectious mononucleosis. , 2004, Acta virologica.

[12]  Kwok-Hung Chan,et al.  Epstein-Barr virus-associated infectious mononucleosis in Chinese children , 2003, The Pediatric infectious disease journal.

[13]  A. Hofmann,et al.  T cell cytokine profile during primary Epstein-Barr virus infection (infectious mononucleosis). , 2003, European cytokine network.

[14]  D. Crawford,et al.  Epstein-Barr virus-recent advances. , 2003, The Lancet. Infectious diseases.

[15]  H. Takada,et al.  Immunological aspects of Epstein-Barr virus infection. , 2002, Critical reviews in oncology/hematology.

[16]  J. Peiris,et al.  Epstein-Barr virus (EBV) infection in infancy. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[17]  S. Leung,et al.  Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. , 1999, Cancer research.

[18]  P. Thall,et al.  Serum cytokine levels in infectious mononucleosis at diagnosis and convalescence. , 1998, Leukemia & lymphoma.

[19]  A. Rickinson,et al.  Acyclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter, double-blind, placebo-controlled study. , 1996, The Journal of infectious diseases.

[20]  A. Sinicco,et al.  Serum cytokine profiles in acute primary HIV-1 infection and in infectious mononucleosis. , 1996, Clinical immunology and immunopathology.

[21]  J. Andersson Clinical and immunological considerations in Epstein-Barr virus-associated diseases. , 1996, Scandinavian journal of infectious diseases. Supplementum.

[22]  R. Heath,et al.  Seroprevalence of antibodies to human herpesviruses in England and Hong Kong , 1994, Journal of medical virology.

[23]  J. Meier,et al.  Epstein-Barr Virus Infections: Biology, Pathogenesis, and Management , 1993, Annals of Internal Medicine.

[24]  J. Meier,et al.  NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management. , 1993, Annals of internal medicine.

[25]  J. Mcgowan,et al.  Guidelines for the use of systemic glucocorticosteroids in the management of selected infections. Working Group on Steroid Use, Antimicrobial Agents Committee, Infectious Diseases Society of America. , 1992, The Journal of infectious diseases.

[26]  J. Rowe,et al.  Intravenous gammaglobulin treatment for immune thrombocytopenia associated with infectious mononucleosis , 1991, American journal of hematology.

[27]  J. Westin,et al.  Use of intravenous immunoglobulins in Epstein-Barr virus induced thrombocytopenia. , 1989, Scandinavian journal of infectious diseases.

[28]  J. Anderson,et al.  New perspectives in nutrition management of diabetes mellitus. , 1988, The American journal of medicine.

[29]  I. Ernberg,et al.  Management of Epstein-Barr virus infections. , 1988, The American journal of medicine.

[30]  J. Phair,et al.  Corticosteroid therapy in Epstein-Barr virus infection. Effect on lymphocyte class, subset, and response to early antigen. , 1986, Archives of internal medicine.